All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
KINNATE BIOPHARMA INC. Last Reported: 3/31/2024 Stock Symbol: KNTE

Business Address

11975 EL CAMINO REAL, STE 101

SAN DIEGO , CA US 92130

Mailing Address

11975 EL CAMINO REAL, STE 101

SAN DIEGO , CA US 92130
Phone Number: 858-299-4699 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 11/30/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $56,998,000.00 $51,662,000.00 $34,507,000.00 $73,570,000.00 $29,261,000.00 $34,502,000.00 $35,065,000.00 $116,096,000.00 $135,009,000.00 $132,991,000.00 $182,389,000.00 $365,462,000.00 -- -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $4,143,000.00 $2,725,000.00 $3,897,000.00 $4,307,000.00 $3,637,000.00 $3,727,000.00 $4,718,000.00 $5,639,000.00 $3,176,000.00 $3,761,000.00 $2,975,000.00 $3,343,000.00 -- -- -- -- --
Total Current Assets $158,177,000.00 $170,301,000.00 $188,600,000.00 $205,288,000.00 $230,837,000.00 $261,175,000.00 $267,133,000.00 $258,690,000.00 $260,712,000.00 $258,780,000.00 $251,172,000.00 $400,203,000.00 -- -- -- -- --
Property Plant and Equipement $2,272,000.00 $2,470,000.00 $2,667,000.00 $2,877,000.00 $3,071,000.00 $3,171,000.00 $3,292,000.00 $956,000.00 $291,000.00 $286,000.00 $283,000.00 $368,000.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $38,000.00 $2,145,000.00 $1,960,000.00 $1,971,000.00 $2,031,000.00 $2,097,000.00 $2,074,000.00 $757,000.00 $319,000.00 $90,000.00 -- -- -- -- -- -- --
Total Assets $173,605,000.00 $190,709,000.00 $216,135,000.00 $243,880,000.00 $278,826,000.00 $302,133,000.00 $323,896,000.00 $366,864,000.00 $386,329,000.00 $404,663,000.00 $386,365,000.00 $400,571,000.00 -- -- -- -- --
Accounts Payable $2,031,000.00 $2,929,000.00 $2,696,000.00 $4,451,000.00 $2,970,000.00 $3,058,000.00 $2,016,000.00 $3,148,000.00 $2,724,000.00 $1,334,000.00 $3,212,000.00 $3,940,000.00 -- -- -- -- --
Accrued Liabilities $9,072,000.00 $11,976,000.00 $12,118,000.00 $12,721,000.00 $13,206,000.00 $11,319,000.00 $8,612,000.00 $9,239,000.00 $7,575,000.00 $6,989,000.00 $4,581,000.00 $3,364,000.00 -- -- -- -- --
Total Current Liabilities $14,278,000.00 $18,289,000.00 $18,515,000.00 $21,118,000.00 $20,358,000.00 $18,792,000.00 $15,167,000.00 -- -- -- -- -- -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-12,000.00 $-147,000.00 $-342,000.00 $-464,000.00 $-1,410,000.00 $-2,559,000.00 $-2,737,000.00 $-524,000.00 $-36,000.00 $-74,000.00 $-40,000.00 $-9,000.00 -- -- -- -- --
Accumulated Deficit $-372,000,000.00 $-355,000,000.00 $-324,221,000.00 $-292,303,000.00 $-259,400,000.00 $-227,800,000.00 $-197,063,000.00 $-143,092,000.00 $-116,933,000.00 $-92,200,000.00 $-70,786,000.00 $-53,329,000.00 -- -- -- -- --
Total Stockholders' Equity $159,327,000.00 $172,420,000.00 $197,620,000.00 $222,762,000.00 $223,468,000.00 $248,341,000.00 $273,729,000.00 $319,477,000.00 $341,030,000.00 $361,340,000.00 $378,572,000.00 $393,267,000.00 -- -- -- $-21,296,000.00 $-17,486,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $173,605,000.00 $190,709,000.00 $216,135,000.00 $243,880,000.00 $278,826,000.00 $302,133,000.00 $323,896,000.00 $366,864,000.00 $386,329,000.00 $404,663,000.00 $386,365,000.00 $400,571,000.00 -- -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 11/30/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $90,800,000.00 $77,397,000.00 $52,886,000.00 $26,559,000.00 $88,150,000.00 $23,548,000.00 $19,767,000.00 $67,166,000.00 $18,729,000.00 $28,908,000.00 $12,666,000.00 -- -- $17,261,000.00 $8,777,000.00 $3,198,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $121,176,000.00 $101,877,000.00 $68,788,000.00 $34,653,000.00 $118,521,000.00 $31,372,000.00 $54,465,000.00 $90,111,000.00 $63,852,000.00 $39,050,000.00 $17,481,000.00 -- -- $10,503,000.00 $11,779,000.00 $4,153,000.00 --
Loss from Operations $-121,176,000.00 $-101,877,000.00 $-68,788,000.00 $-34,653,000.00 $-118,521,000.00 $-31,372,000.00 $-27,406,000.00 $-90,111,000.00 $-63,852,000.00 $-39,050,000.00 $-17,481,000.00 -- -- $-22,282,000.00 $-11,779,000.00 $-4,153,000.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-2.42 $-2.06 $-1.41 $-0.73 $-2.64 $-0.70 $-0.62 $-2.06 $-0.57 $-0.89 $-0.40 -- -- $-2.80 $-3.13 $-1.07 --
Weighted Average Shares Basic 46,575,378 46,392,980 46,036,212 45,409,572 44,065,749 44,151,034 44,002,391 43,601,162 43,559,787 43,506,825 43,477,439 -- -- 3,709,020 3,689,152 3,672,446 --
Earnings Per Share Diluted $-2.42 $-0.65 $-0.68 $-0.73 $-2.64 $-1.92 $-0.62 $-2.06 $-0.57 $-0.89 $-0.40 -- -- $-5.95 $-3.13 $-1.07 --
Weighted Average Shares Diluted 46,575,378 47,094,882 46,655,966 45,409,572 44,065,749 44,151,034 44,002,391 43,601,162 43,559,787 43,506,825 43,477,439 -- -- 3,748,324 3,689,152 3,672,446 --
Common Stock Shares Authorized 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 -- -- -- --
Common Stock Shares Outstanding 47,124,349 47,112,698 47,051,450 46,569,648 44,342,292 44,164,683 44,096,921 43,855,944 43,682,671 43,622,745 43,477,439 43,477,439 -- -- -- -- --
Common Stock Value $5,000.00 $5,000.00 $5,000.00 $5,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com